Capricor Therapeutics, Inc.

CAPR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001133869

SEC filings (opens in a new tab)

No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Capricor Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of CAPR: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	61	1	75	+15
Shares	6.43M	1.63M	8.37M	+3.57M (+74.4%)
Value	$30.7M	$7.77M	$127.3M	+$104.4M (+456.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CAPR in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	1,750,007	$26.6M	0.00%
Superstring Capital Management LP	337,347	$5.13M	4.59%
Ikarian Capital, LLC	300,000	$4.56M	1.42%
Altium Capital Management LP	285,000	$4.33M	1.29%
Point72 Asset Management, L.P.	250,204	$3.81M	0.01%
PFM Health Sciences, LP	152,779	$2.32M	0.13%
Ghost Tree Capital, LLC	125,000	$1.90M	0.65%
StemPoint Capital LP	93,638	$1.42M	0.43%
Schonfeld Strategic Advisors LLC	90,365	$1.37M	0.01%
Boothbay Fund Management, LLC	87,750	$1.33M	0.04%
UBS Oconnor LLC	82,900	$1.26M	0.03%
EAM Investors, LLC	69,925	$1.06M	0.16%
Sphera Funds Management Ltd.	61,698	$938.4K	0.15%
AQR Capital Management LLC	39,616	$602.6K	0.00%
Virtu Financial LLC	30,112	$458.0K	0.03%
Fred Alger Management, LLC	26,241	$399.1K	0.00%
FMR LLC	24,344	$370.3K	0.00%
ADAR1 Capital Management, LLC	24,307	$369.7K	0.06%
MYDA Advisors LLC	24,000	$365.0K	0.10%
Two Sigma Securities, LLC	17,139	$260.7K	0.02%
Balyasny Asset Management LLC	14,999	$228.1K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	14,140	$215.1K	0.00%
Sassicaia Capital Advisers LLC	12,600	$191.6K	0.56%
Manufacturers Life Insurance Company, The	10,558	$160.6K	0.00%
SG Americas Securities, LLC	8,765	$133.0K	0.00%
Russell Investments Group, Ltd.	1,705	$25.9K	0.00%
CWM, LLC	427	$6.00K	0.00%
Capital Performance Advisors LLP	91	$1.38K	0.00%
Sterling Capital Management LLC	34	$517	0.00%

Sold out (14)

Institutions that held Capricor Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CAPR in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Renaissance Technologies LLC	137,500	$655.9K
Marshall Wace, LLP	89,314	$426.0K
Man Group plc	84,654	$403.8K
Citadel Advisors LLC	66,914	$319.2K
Jump Financial, LLC	52,100	$248.5K
Gsa Capital Partners LLP	27,330	$130.0K
Occudo Quantitative Strategies LP	25,151	$120.0K
Alpine Global Management, LLC	24,168	$115.3K
Squarepoint Ops LLC	22,695	$108.3K
Trexquant Investment LP	18,879	$90.1K
Simplex Trading, LLC	17,169	$81.0K
Qube Research & Technologies Ltd	14,433	$68.8K
Engineers Gate Manager LP	13,419	$64.0K
Group One Trading, L.P.	11,695	$55.8K

Not filed for Q3 2024 yet (1)

Institutions that held Capricor Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CAPR in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	1,628,550	$7.77M